|
|||||
|
|
| TIL抗肿瘤治疗的进展 | |
| 引用本文： | 刘进兵,崔殿龙,陈玉强. TIL抗肿瘤治疗的进展[J]. 肿瘤学杂志, 2002, 8(2): 115-118 |
| 作者姓名： | 刘进兵 崔殿龙 陈玉强 |
| 作者单位： | 解放军第174医院,福建,厦门,361003 |
| 摘 要： | 肿瘤浸润性淋巴细胞（tumor infiltrating lymphocyte,TIL)增殖速度快，免疫活性强，比淋巴因子激活的杀伤细胞（lymphokine activated killer cells,LAK)具有更强的特异杀瘤活性，与化学治疗及中医中药联用疗效更好。 |
| 关 键 词： | TIL抗肿瘤治疗 肿瘤浸润性淋巴细胞 杀瘤活性 肿瘤 |
| 文章编号： | 1671-170X(2002)02-0115-04 |
| 修稿时间： | 2001-12-11 |
The Research Progresses of Tumor Infiltrating Lymphocyte Therapy for Cancer |
|
| LIU Jin-bing,CUI Dian-long,CHEN Yu-qiang. The Research Progresses of Tumor Infiltrating Lymphocyte Therapy for Cancer[J]. Journal of Chinese Oncology, 2002, 8(2): 115-118 | |
| Authors: | LIU Jin-bing CUI Dian-long CHEN Yu-qiang |
| Abstract: | Compared with LAK (lymphokine activated killer cells), TIL (tumor infiltrating lymphocyte) has faster proliferation, higher immune activity and stronger killer activity to tumor cells, especially combined with chemotherapy and traditional Chinesemedicine. |
| Keywords: | tumor infiltrating lymphocyte killer activity neoplasms |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |